Samsung

Pharma

Takeda, WuXi, LianBio—Fierce Pharma Asia

Takeda finally won an FDA nod for Eohilia. U.S. lawmakers want sanctions against WuXi for national security reasons. LianBio will shut down. Plus more.

Angus Liu Feb 16, 2024 8:24am

Takeda, Lonza, US legislation—Fierce Pharma Asia

Feb 2, 2024 8:15am

Roche, Eisai, Takeda and more—Fierce Pharma Asia

May 12, 2023 9:15am

For $323M, Samsung Bio purchases land to increase CDMO footprint

Jul 18, 2022 4:53pm

AstraZeneca, Takeda, Biogen, Samsung and more—Fierce Pharma Asia

Feb 4, 2022 6:26am

Samsung unit denies report about Biogen buyout talks

Dec 30, 2021 8:13am